BRUDY LAB S.L.U.

Brudy Hepato is a product design for fatty liver disease. Our Clinical Trials and publications in the TOP medical magazines, have demonstrated that the product is able to reduce the portal vein pressure, which it shows an anti-inflammatory effect in the liver. The product it is based in a specific molecul...

Brudy Neo is a product designed for early-birth babies. All of them require a special attention and nutrients, which they lack due to their shorter pregnancy period. This product give them the require dosage of Omega-3 DHA, needed for the correct development of the brain and the eyes, among other parts. It...

Food supplement for vaginal dryness. The product has been tested in one of the biggest hospital groups. The test length was 3 months and it had a 100% satisfaction in less than a month.The results were seen in less than a month and for the worst cases, was consider a life changer.

Brudy Macula is a food supplement based in our molecule of Omega-3, designed for the macular degeneration (AMD)(Ophthalmology).This is one of our best selling products in several countries around the world, because it has proven high efficiency.The product it is supported by the AREDS 2 Clinical Trial.Due ...

Product for glaucoma pathologies (Ophthalmology). The product has been tested in different Clinical Trials, where it shows an improvement of the dry eye symptoms made by the prostaglandins, reduction of the intraocullar eye preassure. The last Clinical Trial, published in 2023, showed a significant improve...

BrudyAl Plus Multi is an eye drop for the lubrication of the cornea. It is preservatives free and the effect it is immediate. 

Brudy Cosmetics Night Cream, with our molecule Algatrium-AL, which is 6 times more powerful than Coenzyme Q-10 and Retinol. Which make us the most powerful antiaging product known.The molecule is patented by us and we only give exclusive distributions.
It is vegan and it goes with a very sophisticated a...

The aim of this study was to evaluate the effect of citicoline, vitamin C, and docosahexaenoic acid (DHA) in patients with glaucoma. Methods: This was a prospective, randomized study. Patients with glaucoma were randomized to one of four groups and treated for 3 months with vitamin C, DHA, citicoline, or a combination of DHA and citicoline. We conducted a complete ophthalmic examination and visual fields each month and calculated the slopes of field indices. Changes in visual field indices (VFIs) and their slopes were assessed in each group and compared. Results: Seventy-three persons were included in the study.